Business Context and Reporting Period
This Form 6-K filing by Prestige Wealth Inc. (not Aurelion Inc.) covers the month of April 2025, with a report date of April 23, 2025. The filing discloses the execution of an Amended and Restated Securities Purchase Agreement on April 19, 2025, modifying a private placement offering originally announced in March 2025.
Key Financial Metrics
The filing details a private placement offering with the following terms:
- Expected Gross Proceeds: Approximately $7,500,000 (before offering expenses).
- Securities Issued:
- 32,608,696 Class A ordinary shares.
- 24,456,522 Series C ordinary warrants.
- 24,456,522 Series D ordinary warrants.
- Purchase Price: $0.23 per ordinary share and associated warrants.
The filing text does not provide clear values for revenue, profit, cash flow, margins, existing debt, or liquidity metrics.
Material Changes
The Amended and Restated Agreement replaces the Initial Agreement in its entirety. Material changes include:
- Changes in the composition of accredited investors.
- An updated per share purchase price and associated warrant strike prices.
- Revised allocations of securities purchased by each accredited investor.
Outlook, Risks, and Contingencies
Management Commentary and Outlook: The closing of the offering is subject to the satisfaction of customary closing conditions. The company expects to receive the stated gross proceeds upon closing.
Risks and Contingencies:
- The securities were offered and sold in reliance upon an exemption from registration requirements.
- Ordinary shares issuable upon exercise of the warrants are not registered under the Securities Act and cannot be offered or sold in the United States absent registration or an applicable exemption.
- The company has entered into a Registration Rights Agreement to file a registration statement for the resale of the issued securities.
Investor Verification Checklist
- Verify the final closing date and confirmation of the $7,500,000 gross proceeds.
- Review the specific updated warrant strike prices and terms in the attached exhibits (10.3 and 10.4).
- Confirm the identity of the new accredited investors and their specific allocation percentages.
- Monitor the filing of the registration statement for the resale of securities as required by the Registration Rights Agreement.